Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
34 This study considered as primary endpoint the improvement of peripheral neuropathy by at least one grade according to the National Cancer Institute Common Toxicity Criteria version 3.0
Czechia Tesamorelin purity confirmed at 99.7 % Ipamorelin purity confirmed above 99.8 % Assay content verified at 10.90 mg Tesamorelin Assay content verified at 3.57 mg Ipamorelin Molecular ion mass identified at 5135 Da and 993 Da No detectable heavy metals or microbial contamination Dual peptide research blend For research use only not for human or veterinary use For laboratory research only
KKLIU 3621/2022
Each control sample was analyzed in parallel with one patients sample at least
Refrigeration at 28C is insufficient for long-term stability lyophilised peptides stored at 4C retain only 78% potency after six months compared to 96% at 20C
US$ 25.44
US$ 22.56
US$ 26.40
US$ 24.07
US$ 26.46
US$ 22.71
US$ 27.37
US$ 25.69
US$ 25.94